Yolonda L. Colson
Brigham and Women's Hospital, Harvard University, Massachusetts General Hospital
Papers
5
Total Citations
131
H-Index
4
About
Yolonda L. Colson is a pioneering thoracic surgeon and researcher whose work bridges the critical gap between advanced engineering and clinical oncology, with a primary focus on lung cancer diagnostics and treatment. Her research spans three key areas: robotic bronchoscopy for minimally invasive lung biopsies, in-situ chemotherapeutic sensitivity testing, and the modernization of thoracic surgical education. Colson’s most impactful contributions include the first-in-human implantation of multidrug-eluting microdevices for real-time chemotherapeutic sensitivity testing in non-small cell lung cancer (NSCLC), a proof-of-concept study published in 2022 that has already garnered 7 citations and represents a paradigm shift toward personalized adjuvant therapy. She has also led the technical validation of multi-section robotic bronchoscopes with first-person view control, demonstrating in a 2021 study with 18 citations that physicians can more accurately navigate peripheral lung lesions. Her foundational 2008 paper on simulation in thoracic surgical education (70 citations) established her as a thought leader in training methodologies. Colson’s work on conditional autonomy in robot-assisted transbronchial interventions (2025) further positions her at the forefront of semi-autonomous surgical systems. With a career dedicated to translating engineering innovations into clinical practice, she has significantly advanced the safety, precision, and personalization of lung cancer care.
Research Focus
Key Achievements
Top Papers
- 1Envisioning simulation in the future of thoracic surgical education70 citations · 2008
- 2
- 3
- 4
- 5Conditional Autonomy in Robot-Assisted Transbronchial Interventions4 citations · 2025